United States (US) mRNA Therapeutics Market (2025-2031) | Forecast, Share, Size & Revenue, Competitive Landscape, Segmentation, Outlook, Industry, Companies, Growth, Trends, Analysis, Value

Name: United States (US) mRNA Therapeutics Market (2025-2031) | Trends & Outlook
Creator: 6Wresearch
License: https://www.6wresearch.com/privacy-policy

Market Forecast By Type (Prophylactic, Therapeutic), By Application (Infectious Diseases, Oncology, Rare Genetic Diseases, Respiratory Diseases, Others), By End use (Hospitals & Clinics, Research Organizations, Others) And Competitive Landscape

Product Code: ETC9979911	Publication Date: Sep 2024	Updated Date: Aug 2025	Product Type: Market Research Report
Publisher: 6Wresearch	Author: Dhaval Chaurasia	No. of Pages: 75	No. of Figures: 35	No. of Tables: 20

Key Highlights of the Report:

United States (US) mRNA Therapeutics Market Outlook
Market Size of United States (US) mRNA Therapeutics Market, 2024
Forecast of United States (US) mRNA Therapeutics Market, 2031
Historical Data and Forecast of United States (US) mRNA Therapeutics Revenues & Volume for the Period 2021- 2031
United States (US) mRNA Therapeutics Market Trend Evolution
United States (US) mRNA Therapeutics Market Drivers and Challenges
United States (US) mRNA Therapeutics Price Trends
United States (US) mRNA Therapeutics Porter's Five Forces
United States (US) mRNA Therapeutics Industry Life Cycle
Historical Data and Forecast of United States (US) mRNA Therapeutics Market Revenues & Volume By Type for the Period 2021- 2031
Historical Data and Forecast of United States (US) mRNA Therapeutics Market Revenues & Volume By Prophylactic for the Period 2021- 2031
Historical Data and Forecast of United States (US) mRNA Therapeutics Market Revenues & Volume By Therapeutic for the Period 2021- 2031
Historical Data and Forecast of United States (US) mRNA Therapeutics Market Revenues & Volume By Application for the Period 2021- 2031
Historical Data and Forecast of United States (US) mRNA Therapeutics Market Revenues & Volume By Infectious Diseases for the Period 2021- 2031
Historical Data and Forecast of United States (US) mRNA Therapeutics Market Revenues & Volume By Oncology for the Period 2021- 2031
Historical Data and Forecast of United States (US) mRNA Therapeutics Market Revenues & Volume By Rare Genetic Diseases for the Period 2021- 2031
Historical Data and Forecast of United States (US) mRNA Therapeutics Market Revenues & Volume By Respiratory Diseases for the Period 2021- 2031
Historical Data and Forecast of United States (US) mRNA Therapeutics Market Revenues & Volume By Others for the Period 2021- 2031
Historical Data and Forecast of United States (US) mRNA Therapeutics Market Revenues & Volume By End use for the Period 2021- 2031
Historical Data and Forecast of United States (US) mRNA Therapeutics Market Revenues & Volume By Hospitals & Clinics for the Period 2021- 2031
Historical Data and Forecast of United States (US) mRNA Therapeutics Market Revenues & Volume By Research Organizations for the Period 2021- 2031
Historical Data and Forecast of United States (US) mRNA Therapeutics Market Revenues & Volume By Others for the Period 2021- 2031
United States (US) mRNA Therapeutics Import Export Trade Statistics
Market Opportunity Assessment By Type
Market Opportunity Assessment By Application
Market Opportunity Assessment By End use
United States (US) mRNA Therapeutics Top Companies Market Share
United States (US) mRNA Therapeutics Competitive Benchmarking By Technical and Operational Parameters
United States (US) mRNA Therapeutics Company Profiles
United States (US) mRNA Therapeutics Key Strategic Recommendations

Frequently Asked Questions About the Market Study (FAQs):

How does 6Wresearch market report help businesses in making strategic decisions?

Do you also provide customisation in the market study?

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 United States (US) mRNA Therapeutics Market Overview

3.1 United States (US) Country Macro Economic Indicators

3.2 United States (US) mRNA Therapeutics Market Revenues & Volume, 2021 & 2031F

3.3 United States (US) mRNA Therapeutics Market - Industry Life Cycle

3.4 United States (US) mRNA Therapeutics Market - Porter's Five Forces

3.5 United States (US) mRNA Therapeutics Market Revenues & Volume Share, By Type, 2021 & 2031F

3.6 United States (US) mRNA Therapeutics Market Revenues & Volume Share, By Application, 2021 & 2031F

3.7 United States (US) mRNA Therapeutics Market Revenues & Volume Share, By End use, 2021 & 2031F

4 United States (US) mRNA Therapeutics Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing investment in research and development of mRNA therapeutics

4.2.2 Growing prevalence of chronic diseases requiring innovative treatment options

4.2.3 Rising adoption of personalized medicine and targeted therapies in the healthcare industry

4.3 Market Restraints

4.3.1 Regulatory challenges and uncertainties surrounding mRNA therapeutics

4.3.2 High costs associated with the development and production of mRNA-based drugs

4.3.3 Limited awareness and acceptance of mRNA therapeutics among healthcare providers and patients

5 United States (US) mRNA Therapeutics Market Trends

6 United States (US) mRNA Therapeutics Market, By Types

6.1 United States (US) mRNA Therapeutics Market, By Type

6.1.1 Overview and Analysis

6.1.2 United States (US) mRNA Therapeutics Market Revenues & Volume, By Type, 2021- 2031F

6.1.3 United States (US) mRNA Therapeutics Market Revenues & Volume, By Prophylactic, 2021- 2031F

6.1.4 United States (US) mRNA Therapeutics Market Revenues & Volume, By Therapeutic, 2021- 2031F

6.2 United States (US) mRNA Therapeutics Market, By Application

6.2.1 Overview and Analysis

6.2.2 United States (US) mRNA Therapeutics Market Revenues & Volume, By Infectious Diseases, 2021- 2031F

6.2.3 United States (US) mRNA Therapeutics Market Revenues & Volume, By Oncology, 2021- 2031F

6.2.4 United States (US) mRNA Therapeutics Market Revenues & Volume, By Rare Genetic Diseases, 2021- 2031F

6.2.5 United States (US) mRNA Therapeutics Market Revenues & Volume, By Respiratory Diseases, 2021- 2031F

6.2.6 United States (US) mRNA Therapeutics Market Revenues & Volume, By Others, 2021- 2031F

6.3 United States (US) mRNA Therapeutics Market, By End use

6.3.1 Overview and Analysis

6.3.2 United States (US) mRNA Therapeutics Market Revenues & Volume, By Hospitals & Clinics, 2021- 2031F

6.3.3 United States (US) mRNA Therapeutics Market Revenues & Volume, By Research Organizations, 2021- 2031F

6.3.4 United States (US) mRNA Therapeutics Market Revenues & Volume, By Others, 2021- 2031F

7 United States (US) mRNA Therapeutics Market Import-Export Trade Statistics

7.1 United States (US) mRNA Therapeutics Market Export to Major Countries

7.2 United States (US) mRNA Therapeutics Market Imports from Major Countries

8 United States (US) mRNA Therapeutics Market Key Performance Indicators

8.1 Clinical trial success rates for mRNA therapeutics

8.2 Number of partnerships and collaborations in the mRNA therapeutics space

8.3 Rate of FDA approvals for mRNA-based drugs

8.4 Patient enrollment in mRNA therapeutics clinical trials

8.5 Number of publications and citations related to mRNA therapeutics

9 United States (US) mRNA Therapeutics Market - Opportunity Assessment

9.1 United States (US) mRNA Therapeutics Market Opportunity Assessment, By Type, 2021 & 2031F

9.2 United States (US) mRNA Therapeutics Market Opportunity Assessment, By Application, 2021 & 2031F

9.3 United States (US) mRNA Therapeutics Market Opportunity Assessment, By End use, 2021 & 2031F

10 United States (US) mRNA Therapeutics Market - Competitive Landscape

10.1 United States (US) mRNA Therapeutics Market Revenue Share, By Companies, 2024

10.2 United States (US) mRNA Therapeutics Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Africa mRNA Therapeutics Market

Equatorial Guinea mRNA Therapeutics Market

Eritrea mRNA Therapeutics Market

Ethiopia mRNA Therapeutics Market

Fiji mRNA Therapeutics Market

Finland mRNA Therapeutics Market

Global mRNA Therapeutics Market

Middle East mRNA Therapeutics Market

North America mRNA Therapeutics Market

Global Go To Market Strategy - 2030

Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.

By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.

To discover high-growth global markets and optimize your business strategy:

Click Here